AnalystsDaina Graybosch
Daina Graybosch's Stock Forecasts

Analyst Ranking
Bottom 2%
#4805 out of 4868 analysts
Average Return
-21.98%
Win Rate
31%27 out of 86
Risk vs Reward
Poor
Good

Daina Graybosch's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Arcellx IncACLX
+366.89%$8.91$41.60
2022-05-12 -
2023-05-12
Buy
F Star Therapeutics IncFSTX
+162.96%$2.43$6.39
2022-05-10 -
2022-06-24
Buy
Arcellx IncACLX
+127.81%$30.53$69.55
2023-03-29 -
2024-03-28
Buy
Arcellx IncACLX
+115.76%$14.02$30.25
2022-03-28 -
2023-03-28
Buy
Affimed NvAFMD
+103.18%$40.90$83.10
2020-06-23 -
2021-06-24
Buy

Daina Graybosch Analyst Color

Get additional color on Daina Graybosch's coverage of popular stocks

Daina Graybosch's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
2seventy Bio IncTSVT
5Hold$5.00+0.20%Downgrades
2 months ago
Merck & Co IncMRK
16Buy$119.00+39.67%Maintains
4 months ago
Lava Therapeutics NvLVTX
6Hold$2.00+60.00%Downgrades
5 months ago
Bolt Biotherapeutics IncBOLT
8Hold$1.00+181.69%Downgrades
a year ago
Arcellx IncACLX
5Buy$39.00N/AMaintains
2 years ago
Nektar TherapeuticsNKTR
7Hold$3.00N/AMaintains
2 years ago
Century Therapeutics IncIPSC
4Buy$14.00N/AMaintains
2 years ago
Fate Therapeutics IncFATE
6Buy$10.00N/AMaintains
2 years ago
Affimed NvAFMD
7Buy$60.00N/AMaintains
2 years ago
Innate Pharma SaIPHA
9Buy$9.00N/AMaintains
2 years ago
Arcus Biosciences IncRCUS
2Buy$38.00N/AMaintains
2 years ago
Molecular Partners AgMOLN
4Hold$8.00N/ADowngrades
3 years ago
Biontech SeBNTX
13Buy$224.00N/AMaintains
3 years ago
Nkarta IncNKTX
1Buy$30.00N/AInitiates Coverage On
3 years ago
F Star Therapeutics IncFSTX
4Hold$7.00N/ADowngrades
3 years ago
Iteos Therapeutics IncITOS
4Buy$59.00N/AMaintains
3 years ago
Werewolf Therapeutics IncHOWL
3Buy$17.00N/AMaintains
3 years ago
Ars Pharmaceuticals IncSPRY
6Hold$1.80N/ADowngrades
3 years ago
Compugen LtdCGEN
2Buy$9.00N/AMaintains
3 years ago
Genocea Biosciences IncGNCAQ
1Buy$6.00N/AMaintains
4 years ago
Synthorx IncTHOR
1Hold$68.00N/ADowngrades
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.